Issuance of Stock Acquisition Rights for Directors
First written in FY2017-Q2. 12 of 14 entries say "Advanced", first in FY2017. Latest entry: FY2024.
The whole theme swung hardest in 2024: 4 of 33 companies on the "Worse" side.
12 other companies' latest entry also says "Dropped".
- FY2024DroppedAnnual report
「The Company discontinued its stock option plan upon introducing a restricted stock compensation plan from the fiscal year ending March 2024. Accordingly, no stock options were granted during the consolidated fiscal year under review, and no existing stock options remained outstanding at the end of that consolidated fiscal year.」
The stock option plan was discontinued following the introduction of a restricted stock compensation plan, and no existing balance remained at the end of the fiscal year. - FY2023AdvancedAnnual report
「Of the 3,000 shares granted under the Eleventh Series of Stock Acquisition Rights, rights to 2,250 shares have vested, leaving 750 shares unvested.」
Of the 3,000 shares granted under the Eleventh Series of Stock Acquisition Rights approved on 22 July 2022, rights to 2,250 shares vested. - FY2023-Q2AdvancedAnnual report
「Resolution date 22 July 2022 Category and number of grantees (people) Directors of the Company: 4 Number of stock acquisition rights (units)* 30 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares: 3,000 (Note 1) Exercise period for the stock acquisition rights* 13 August 2022 to 12 August 2052」
Based on the resolution of 22 July 2022, 30 stock acquisition rights, representing 3,000 underlying shares, were issued to 4 directors. - FY2022AdvancedAnnual report
「Of the 2,200 shares granted under the Tenth Series of Stock Acquisition Rights, rights to 1,650 shares have vested, leaving 550 shares unvested.」
Of the 2,200 shares granted under the Tenth Series of Stock Acquisition Rights approved on 26 July 2021, rights to 1,650 shares vested. - FY2022-Q2AdvancedAnnual report
「Resolution date: 26 July 2021 / Category and number of grantees (people): Directors of the Company, 3 / Number of stock acquisition rights (units): 22 / Class, details and number of shares underlying the stock acquisition rights (shares): Common shares, 2,200 / Exercise period for the stock acquisition rights: 13 August 2021 to 12 August 2051」
Based on the resolution of 26 July 2021, 22 stock acquisition rights, representing 2,200 underlying shares, were issued to 3 directors. - FY2021AdvancedAnnual report
「Of the 3,600 shares granted under the Ninth Series of Stock Acquisition Rights, rights to 2,700 shares have vested, leaving 900 shares unvested.」
Of the 3,600 shares granted under the Ninth Series of Stock Acquisition Rights approved on 27 July 2020, rights to 2,700 shares vested. - FY2021-Q2AdvancedAnnual report
「Resolution date 27 July 2020 Category and number of grantees (people) Directors of the Company: 4 Number of stock acquisition rights (units)* 36 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares: 3,600 (Note 1) Exercise period for the stock acquisition rights* 13 August 2020 to 12 August 2050」
Based on the resolution of 27 July 2020, 36 stock acquisition rights, representing 3,600 underlying shares, were issued to 4 directors. - FY2020-Q2AdvancedAnnual report
「Resolution date 24 July 2019 Category and number of grantees (people) Directors of the Company: 4 Number of stock acquisition rights (units)* 44 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares: 4,400 (Note 1) Exercise period for the stock acquisition rights* 10 August 2019 to 9 August 2049」
Based on the resolution of 24 July 2019, 44 stock acquisition rights, representing 4,400 underlying shares, were issued to 4 directors. - FY2019AdvancedAnnual report
「Seventh Series of Stock Acquisition Rights / Common shares: 3,500 shares / Vested: 2,925 shares / Exercised: 1,200 shares / Unexercised balance: 1,725 shares」
Of the 3,500 shares granted under the Seventh Series of Stock Acquisition Rights approved on 23 July 2018, rights to 2,925 shares vested and rights to 1,200 shares were exercised. - FY2019-Q2AdvancedAnnual report
「Resolution date 23 July 2018 Category and number of grantees (people) Directors of the Company: 6 Number of stock acquisition rights (units)* 35 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares: 3,500 (Note 1) Exercise period for the stock acquisition rights* 10 August 2018 to 9 August 2048」
Based on the resolution of 23 July 2018, 35 stock acquisition rights, representing 3,500 underlying shares, were issued to 6 directors. - FY2018AdvancedAnnual report
「Sixth Series of Stock Acquisition Rights / Resolution date: 24 July 2017 / Category and number of grantees: 6 directors of the Company, excluding outside directors / Class and number of shares granted: common shares, 4,300 shares」
Of the 4,300 shares granted under the Sixth Series of Stock Acquisition Rights approved on 24 July 2017, rights to 3,225 shares vested, leaving 1,075 shares unvested. - FY2018-Q2AdvancedAnnual report
「Resolution date 24 July 2017 Number of stock acquisition rights (units) 43 (Note 1) Number of shares underlying the stock acquisition rights (shares) 4,300 (Note 1) Exercise period for the stock acquisition rights 10 August 2017 to 9 August 2047」
Based on the resolution of 24 July 2017, 43 stock acquisition rights, representing 4,300 underlying shares, were issued. - FY2017AdvancedAnnual report
「Of the 2,000 shares granted under the Fifth Series of Stock Acquisition Rights, rights to 1,500 shares have vested, leaving 500 shares unvested.」
Of the 2,000 shares granted under the Fifth Series of Stock Acquisition Rights issued in Q2, rights to 1,500 shares vested. - FY2017-Q2First statedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows. / Resolution date: 25 July 2016 / Number of stock acquisition rights: 20 / Number of shares underlying the stock acquisition rights: 2,000 shares / Exercise period for the stock acquisition rights: 11 August 2016 to 10 August 2046」
Based on the resolution of 25 July 2016, 20 stock acquisition rights, representing 2,000 underlying shares, were issued.